ACCA Strategic Professional · Strategic Business Leader · Strategic choices
Brightwater Utilities, a regulated water company with stable but capped returns, is considering buying a chain of fitness clubs, a business unrelated to its existing operations, purely because the fitness sector is growing fast. Which is the most valid criticism using Ansoff's matrix?
The move is unrelated diversification, the riskiest Ansoff quadrant, with new products in new markets. The criticism is that sector growth alone is weak justification when Brightwater has no relevant competences or synergies, so success depends on skills it does not have.
- AIt is market penetration and will cannibalise existing water sales
- BIt is diversification, the riskiest quadrant, and the stated rationale ignores the lack of relevant competences and synergiesCorrect
- CIt is product development and so depends on existing customers
- DIt is market development and so only needs new distribution channels
Explanation
New products in new markets is diversification, which Ansoff identifies as the highest-risk option. Unrelated diversification offers little synergy and uses none of the firm's core competences; sector growth alone is not a sufficient justification. Other options misclassify the move.
Did you get it right without looking?
One question tells you little. A timed set on Strategic choices shows your real accuracy, how long you take and where you lose marks.
More Strategic choices questions
- Valdora Foods sells identical packaged snacks in 30 countries. It manufactures in three giant plants, uses one global brand and one advertis…
- Baltic Marine plans to enter a new product market where it has strong existing technical skills, a loyal customer base and time to build gra…
- Harlow Components makes standard steel fasteners sold mainly on price. It has the lowest unit cost in its industry through large-scale produ…
- Halvern Mobility, a car maker, partners with a software firm and a battery supplier to offer a subscription mobility service. Its CEO says t…
- Brelden Pharma has a successful range of established drugs generating strong cash. Its board wants to explore a radical new gene-therapy app…
- Tidal Motors, a petrol car maker selling to private motorists, launches an electric van for logistics companies, a segment it has never serv…